Therapeutic Duplication¶

The medication-safety failure where uncoordinated prescribers each place a defensible order that lands on the same pharmacologic target, so additive exposure overruns the therapeutic window — a harm that lives in the set of orders, not in any single one.

Core Idea¶

Therapeutic duplication is the medication-safety failure mode in which two or more agents acting on the same pharmacologic target are prescribed to one patient in parallel, without any prescriber intending the combination, so the patient receives additive dose or side effects beyond what any order contemplates. Its defining character is that the pathology is not localised in any single prescription — each may be defensible in isolation. The defect lies in the set of concurrent orders read as a whole against a shared target class.

Scope of Application¶

Therapeutic duplication lives across the prescribing and medication-review subfields of medication safety and pharmacy practice.

Medication reconciliation at care transitions — where the full list is finally read end-to-end as one set.
E-prescribing decision support — duplicate-therapy alerts firing when a new agent shares a class.
Hospital pharmacy review — a pharmacist verifying an order set against the active profile.
Geriatric polypharmacy audit — deprescribing in patients on a dozen-plus agents.
Oncology regimen reconciliation — confirming supportive-care and chemo orders do not stack.
Combination-product surveillance — surfacing active ingredients hidden inside combination products.

Clarity¶

Naming therapeutic duplication makes legible a harm that order-by-order review structurally cannot see: when each prescription is correct in isolation, an audit of prescriptions one at a time finds nothing, yet the patient is overexposed. The label relocates the defect from the element to the set. It also sharpens the crucial distinction — intended combination therapy versus unintended duplication — which look identical on the list and differ only by a coordinating intent.

Manages Complexity¶

A long medication list is a quadratic sprawl if certified by checking every drug against every other. Duplication changes the unit of analysis from the pair to the pharmacologic class: instead of "do any two interact?", ask per class "is more than one agent already acting on this target?" That collapses an all-pairs search into a class-by-class scan, with one further parameter — intended versus unintended — resolving the verdict and a fixed transition-layer remedy.

Abstract Reasoning¶

The concept licenses a set-level diagnostic — inferring harm from the configuration of orders even when each is blameless. It grounds an interventionist reframing from drug pair to pharmacologic class — the class-scan, decomposing combination products into ingredients. Its decisive boundary-drawing is the intended-versus-unintended one-bit test on every hit. And it keeps a clean line against pharmacokinetic interaction — additive same-target exposure harms with no interaction at all.

Knowledge Transfer¶

Within medicine the concept transfers as mechanism with full fidelity across services and drug classes — the harm-bearing set, the class-scan, the intent disambiguation, and the reconciliation remedy carry intact because pharmacologic class and additive same-target exposure are literal everywhere in prescribing. Beyond medicine the named concept does not transfer — importing it is metaphor. The shape that recurs — uncoordinated parallel interventions compounding on a shared target — is owned by the parent primes (set-level configuration harm, coordination failure, redundancy miscalibration); the medication apparatus stays home.

Relationships to Other Abstractions¶

Current abstraction Therapeutic Duplication Domain-specific

Parents (3) — more general patterns this builds on

Therapeutic Duplication is a kind of Medication Error Domain-specific

Therapeutic Duplication is a Medication Error specialized to an unintended concurrent same-target overlap created across fragmented orders.
Therapeutic Duplication presupposes, typical Therapeutic Window Prime

Harm-relevant Therapeutic Duplication typically presupposes a Therapeutic Window whose upper margin the uncoordinated additive exposure approaches or crosses.
Therapeutic Duplication is a decomposition of Systemic Fragmentation Prime

Removing medication vocabulary leaves siloed local actors making defensible decisions whose missing cross-boundary integration produces duplicated global action and set-level harm.

Children (1) — more specific cases that build on this

Polypharmacy Domain-specific is part of, conditional Therapeutic Duplication

Polypharmacy conditionally contains Therapeutic Duplication when fragmented additions place multiple uncoordinated agents on one pharmacological target.

Hierarchy paths (62) — routes to 17 parentless roots

Therapeutic Duplication → Medication Error → Medical Error → Swiss Cheese Model (Layered Defense with Aligning Holes) → Conjunctive Path Activation → Causality → Dependency

Show alternative paths (61)

Neighborhood in Abstraction Space¶

Therapeutic Duplication sits in a moderately populated region (48^th percentile for distinctiveness): it has near-neighbors but no dense thicket of look-alikes.

Family — Pharmacokinetics & Drug Response (19 abstractions)

Nearest neighbors

Computed from structural-signature embeddings · 2026-07-12